In total, 17,369,476 individuals received ≥1 COVID-19 vaccine dose, and 11,833,911 individuals had received the full schedule by June 2022. National uptake was 6% in September (Q3) 2021, 42% in December (Q4) 2021 and 63% by   June (Q2) 2022. Coverage (2% in Q3 2021, 16% in Q4, 2021, and 42% in Q2 2022) was below WHO targets. Western region (33.2%) had significantly higher coverage than eastern (31.4%), Central (22.4%) and northern regions (21.6%) (p&amp;lt;0.001). Females (10.6%) had higher coverage than males (8.6%) (p50 years of age had higher coverage (24.9%) than persons aged 40-49 (21.8%), 30-39 (19.0%), 18-29 (4.7%) and 12-17 (2.9%) years (p&amp;lt;0.001).